IP Library Granted Patent US 9,890,412
Granted Patent B2
US 9,890,412 · App. 14/391,897 · Granted Feb 13, 2018

Method for quantifying subfraction of cholesterol (−C) in high-density lipoprotein (HDL)

Inventors: Yasuki Itoh (Niigata, JP); Hitoshi Chiba (Hokkaido, JP)
Assignees: Denka Seiken Co., Ltd.; National University Corporation Hokkaido University
C12Q1/60G01N33/92G01N2333/775
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,890,412
App. No.
14/391,897
Granted
Feb 13, 2018
Kind
B2
Abstract

Provided is a method for separately or simultaneously quantifying whole HDL-C and cholesterol in HDL subfractions: ApoE-Containing HDL-C and ApoE-deficient HDL-C. A method for enzymatically and separately quantifying cholesterol in the ApoE-deficient HDL comprising: adding a surfactant composed of a polyoxyethylene benzyl phenyl ether derivative to a test sample in a final concentration of 0.05 to 0.10%, reacting the test sample with cholesterol esterase and cholesterol oxidase, and quantifying hydrogen peroxide generated. A method for enzymatically and separately quantifying cholesterol in ApoE-Containing HDL comprising: adding a surfactant composed of a polyoxyethylene benzyl phenyl ether derivative so as to obtain a final concentration of 0.15 to 0.75%, reacting the test sample with cholesterol esterase and cholesterol oxidase, and quantifying hydrogen peroxide generated.

Claims (9)

1. A method for quantifying cholesterol in ApoE-Containing HDL, comprising:

(i) adding surfactant polyoxyethylene benzyl phenyl ether to a test sample in a final concentration of 0.05 to 0.10 wt %,

reacting the test sample with cholesterol esterase and cholesterol oxidase, and

removing cholesterol in HDL except the ApoE-Containing HDL; and

(ii) subsequently adding the same surfactant used in step (i) so as to obtain a final concentration of 0.20 to 0.75 wt %, and

reacting the test sample with cholesterol esterase and cholesterol oxidase, and

quantifying hydrogen peroxide generated to quantify cholesterol in the ApoE-Containing HDL.

2. The method according to claim 1 , wherein total HDL-cholesterol is quantified based on (i) the quantification value of cholesterol in the ApoE-deficient HDL obtained by adding surfactant polyoxyethylene benzyl phenyl ether to the test sample in a final concentration of 0.05 to 0.10 wt %, reacting the test sample with cholesterol esterase and cholesterol oxidase, and quantifying hydrogen peroxide generated; and (ii) a quantification value of cholesterol in the ApoE-Containing HDL obtained by adding the same surfactant as step (i) to the test sample so as to obtain a final concentration of 0.20 to 0.75 wt %, reacting the test sample with cholesterol esterase and cholesterol oxidase, and quantifying hydrogen peroxide generated.

3. The method according to claim 1 , wherein cholesterol in the ApoE-deficient HDL, cholesterol in ApoE-Containing HDL, and total HDL-cholesterol are simultaneously quantified by a general automatic analyzer using a single sample.

Assignments (2)
MERGER Recorded Oct 5, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 053976/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2014
From: ITOH, YASUKI; CHIBA, HITOSHI
To: DENKA SEIKEN CO., LTD.; NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
Reel/Frame 033931/0274 →
Priority Claims (1)
JP 2012-090423 · Apr 11, 2012 · national
Continuity (1)
Related Publication 20150079616A1 · Mar 19, 2015